Sahmoud Tarek
Known title: Chief Medical OfficerCIK: 0001861811
Sahmoud Tarek's purchase track record
Sahmoud Tarek has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/16/2022 | CNTX | $20K | -37.5% | -56.7% | -3.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CNTX | ▲ Buy | Open Market | 10,000 | $20K | 8/16/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
CNTX appears on Yahoo's recent strong negative rating lists
Yahoo listed Context Therapeutics in its strong negative rating lists for October 13 and October 15. The inclusion reflects recent analyst concerns about the company's outlook. The stock is currently trading with a low RSI and near its identified support level, which aligns with the negative sentiment.
CNTX appears on Yahoo's recent strong negative rating lists. Yahoo listed Context Therapeutics in its strong negative rating lists for October 13 and October 15. The inclusion reflects recent analyst concerns about the company's outlook. The stock is currently trading with a low RSI and near its identified support level, which aligns with the negative sentiment.